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Abstract
Background: Osteoporosis, characterized by low bone mineral density (BMD) and high bone fracture risk, is
prevalent in Thai menopausal women. Genetic factors are known to play a key role in BMD. Low density lipoprotein
receptor-related protein 5 (LRP5), a co-receptor in the Wnt/beta-catenin pathway, is involved in many aspects
of bone biology. As coding single nucleotide polymorphisms (cSNPs) of LRP5, including A1330V (rs3736228),
and Asian-related Q89R (rs41494349) and N740N (rs2306862), are associated with lowered BMD, this study aimed
to determine the relationship between these LRP5 polymorphisms and BMD in 277 Thai menopausal women.
Results: Only rs3736228 deviated from the Hardy–Weinberg equilibrium of allele frequency (p = 0.022). The
median, range and p value for the BMD related to each SNP parameter were compared (Mann–Whitney U test).
Significant differences were observed between wild-type and risk alleles for both rs3736228 (total radial, p = 0.011;
and radial 33, p = 0.001) and rs2306862 (radial 33: p = 0.015) SNPs, with no significant difference for rs41494349
SNP. Linkage disequilibrium was strong for both rs3736228 and rs2306862 SNPs. Haplotype analysis identified high
CC frequency in both normal and osteopenia/osteoporosis groups, with a significant odds ratio for carrying the
TT haplotype; however, this was non-significant after adjusting for age. Multivariate binary logistic regression
analysis performed for rs3736228 showed that individuals with a body mass index <25 kg/m2 had an increased
risk of osteoporosis for each decade, but the polymorphism had no effect.
Conclusions: This study did not identify LRP5 polymorphisms as a risk factor for osteoporosis in Thai menopausal
women. Further studies with larger sample sizes are needed to further clarify the role of LRP5 as a genetic
determinant of osteoporosis.
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Background
Osteoporosis, a common metabolic bone disease, is
characterized by low bone mineral density (BMD) and
high risk of bone fracture [1]. During 40–50 years of age,
women tend to lose bone mass significantly during the
menopausal period because of greater bone resorption. In
Thailand, the prevalence of osteoporosis in the lumbar
spine and femoral neck of women aged 40–80 years is
19.8 % and 13.6 %, respectively. These figures are less than
5 % in women under 50 years of age, but increase more
than 50 % in those older than 70 years of age [2]. Among
factors which have an influence on osteoporosis, genetic
factors play an essential role in bone density regulation.
To date, individual genome-wide association studies
(GWASs) and meta-analyses of GWASs have discovered
more than 70 genes/loci to be associated with BMD
phenotypes [3], particularly ZBTB40, GPR177, FGFRL1,
MEF2C, ESR1, WNT16, TNFRSF11B, SOX6, LRP5,
AKAP11, and FOXL1 [4, 5]. Further, candidate gene* Correspondence: anong.kit@mahidol.ac.th1Department of Tropical Nutrition and Food Science, Faculty of Tropical
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association studies have suggested additional loci, e.g.,
VDR [6], COL1A1 [7],TGFB1 [8] and PTH [9].
The Wnt signaling pathway has an essential role in the
regulation of many cellular processes, such as cell
growth, differentiation, migration, polarity and apoptosis.
In addition, the canonical Wnt/beta-catenin pathway is
particularly involved with bone biology [10]. The trans-
membrane protein, low density lipoprotein receptor-
related protein 5 (LRP5), acts as a co-receptor for the
Wnt signaling pathway and it is widely expressed in
many tissues including bone. In bone, it expresses by
osteoblasts of the endoosteal and trabecular bone sur-
face [11]. Analysis of two monogenic disorders having
extreme bone phenotypes reveals that LRP5 as a modu-
lator of bone metabolism. Osteoporosis-pseudoglioma
(OPPG), an autosomal recessive disease characterized by
bone thinning and blindness due to abnormal eye devel-
opment has been linked to loss of function mutation in
LRP5 [12]. OPPG-causing frameshift or nonsense muta-
tions in LRP5 extracellular domain have been identified
and mutant LRP5 protein can be synthesized but not se-
creted. Dominant negative secreted form of LRP5 can
reduce bone thickness in mouse calvarial explants [12].
In contrast to OPPG, an autosomal dominant high bone
mass (HBM) traits results from a gain of function muta-
tion in LRP5. Genetic studies of two unrelated families
with increased BMD (spinal Z scores ≥ 5) identify a sin-
gle missense mutation of LRP5 resulting in amino acid
substitution of a conserved glycine by valine at residue
171 (G171V) [13, 14]. Serum markers of affected indi-
viduals show increased bone formation but normal bone
resorption [13]. Level of known target of Wnt signaling,
the extracellular matrix protein fibronectin is also in-
creased. Cell expressing LRP5V171 can abolish action of
endogenous Wnt inhibitor, Dkk-1 resulting in increased
LRP5 function and excessive bone formation [13]. Mice
carrying both types of mutations have high and low bone
mass phenotypes resembled that of human [11, 15]. Pre-
vious qualitative trait locus (QTL) work suggests that
chromosome 11 q12–13 region where LRP5 located,
may have important role in general BMD variance [16].
A cohort of British Caucasian adults covering broad
range BMD studied by Koay et al demonstrates that
LRP5 polymorphisms is a genetic determinant of normal
BMD variation [17].
Several coding single nucleotide polymorphisms
(cSNPs) of LRP5 have been reported. The most fre-
quently studied and likely functional polymorphism of
LRP5, A1330V (rs3736228) in exon 18, has been shown
to affect BMD and increase fracture risk in various
groups, including postmenopausal women [18–21]. It lo-
cates in LDL-repeat domain of LRP5 protein which may
be responsible for mediating the receptor-ligand inter-
action [22]. HEK293T cells containing the LRP5-V1330
coexpressed with Wnt3a has reduced transcriptional
activity measuring by TCF-Lef reporter assay as
compared to wild type allele implying the functional
significance of A1330V variant [19]. Another two LRP5
cSNPs, Q89R (rs41494349) in exon 2 and N740N
(rs2306862) in exon 10 are chosen because of their
association with low BMD in Asian population [23–25].
Q89R is localized on the first of four beta-propellers,
while N740N is on the third one [26]. Structural analysis
of mutation occurred in the first propeller domain of
LRP5 suggest changing in local hydrophobic environ-
ment and subsequently possibly affecting interaction of
LRP5 with other proteins [14]. Although the function of
each LRP5 protein domain is still uncertain, these 3
cSNPs could have influence on LRP5 biological function
and BMD. Therefore, LRP5 genetic variations may have
an effect on osteoporosis within the Thai population.
Thus, we studied the relationship of LRP5 polymor-
phisms (rs3736228, rs41494349 and rs2306862) and
BMD in Thai menopausal women.
Results
Basic characteristics, including age, body mass index
(BMI) and BMD of menopausal women, are shown in
Table 1. Among the genotype distribution of LRP5 poly-
morphisms studied, those of rs41494349 and rs2306862
did not deviated significantly from Hardy–Weinberg
Equilibrium (HWE), which is in contrast with rs3736228
(p = 0.022) (Table 2). Neither rs41494349 nor rs2306862
SNP was associated with risk of osteopenia/osteoporosis
in terms of dominant or recessive model (Table 3).
However, the genetic model of dominance for rs3736228
was assumed due to none of its homozygous (T/T) variant
present.
From Table 4, it can be observed that the wild-type
group of rs3736228 was older than the risk allele group
(CC vs CT, 58 vs 55, respectively, p = 0.002). However,
BMI was comparable between these groups. From the
various sites examined, the Mann–Whitney U test
revealed a statistically significant difference between total
radial and radial 33 BMD for rs3736228 and rs2306862.
Table 1 Characteristic data of the studied population
Characteristic Median (Min–Max) Number
Age (years) 57 (45–75) 277
Body mass index (BMI) (kg/m2) 22.79 (15.46–39.54) 277
Lumbar spine BMD (g/cm2) 1.013 (0.700–1.564) 205
Femoral neck BMD (g/cm2) 0.788 (0.434–1.224) 233
Total radial BMD (g/cm2) 0.477 (0.262–0.961) 277
Radial 33 BMD (g/cm2) 0.626 (0.315–0.818) 277
Total hip BMD (g/cm2) 0.871 (0.229–1.322) 233
BMD = bone mineral density
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For rs3736228, the total radial BMD of the individuals or
group carrying the risk allele (CT) was significantly higher
than the wild-type group (CC), p = 0.011. In addition, the
radial 33 BMD was higher in the individuals or group
carrying the risk allele of rs3736228 (CT, p = 0.001) and
rs2306862 (CT + TT, p = 0.015). However, there were no
statistically significant differences between BMD values of
the wild-type (AA) and risk (AG + GG) allele carrier
group of the rs41494349 SNP.
Because a greater radial 33 BMD was found in both
rs3736228 and rs2306862 SNP risk allele carrier
groups compared with their respective wild-type
groups, it was of interest to determine whether a
genotypic additive effect was present. Linkage disequi-
librium (LD) analysis was conducted and a high level
of LD was observed (D’/r2 = 0.9294/0.7549). Haplo-
type analysis was performed to observe the haplotypic
effect of these two genotypes on causing osteopenia/
osteoporosis using radial 33 BMD T-score cut-off. In
both the normal and osteopenia/osteoporosis groups,
CC haplotype was found at high frequency. The odds
ratio of carrying the TT haplotype was found to be
0.48 (95 % CI = 0.26–0.88, p = 0.018) in comparison
to the more common CC haplotype (Table 5). How-
ever, after adjusting for age, the TT haplotype was
not found to be statistically significant: OR = 0.62 (95 %
CI = 0.32–1.20, p = 0.160).
Although we did not detect an association between
osteopenia/osteoporosis and haplotypic effect of the
two SNPs, rs3736228 and rs2306862, they belonged to
a big LD block comprising other variants in HapMap
genotype data of Han Chinese in Beijing, China
(CHB) and Japanese in Tokyo, Japan (JPT) population
(Fig. 1). Haploview LD map of LRP5 showed almost
similar LD structure in both populations (Additional file 1
Figure S1). Both variants were in complete LD in
CHB (block 6; D’/r2 = 1/0.913) and JPT despite
located in non-adjacent blocks (block 4 and 6; D’/r2 =
1/0.941).
Univariate analysis was performed to determine if
any factors contributed to osteoporosis, represented
by total radial BMD T-score cut-off [27]. The factors
tested were the rs3736228 genotype and those affect-
ing osteoporosis risk, age and BMI. The combined
effect of these factors was analyzed using binary logis-
tic regression analysis (Table 6). For individuals with
a BMI of less than 25 kg/m2, for every decade older,
there was an increased risk of osteoporosis. The
rs3736228 polymorphism had no effect.
Table 2 Genotype distributions in subjects
Genotype All subjects (N) Allele frequency HWE (p-value)
rs3736228
CC 210 C = 0.88 0.022
CT 67 T = 0.12
TT 0
rs41494349
AA 245 A = 0.94 0.239
AG 28 G = 0.06
GG 2
rs2306862
CC 193 T = 0.86 0.336
CT 65 C = 0.14
TT 3
p<0.05 was considered statistically significant
Table 3 Association between LRP5 SNPs and osteopenia/osteoporosis in studied population
SNPs/Genetic model/Genotype Normal N (%) Osteopenia/osteoporosis N (%) OR (95% CI) p-value
rs41494349
Dominant model
A/A 54 (90.0) 191 (88.8) Reference
A/G-G/G 6 (10.0) 24 (11.2) 1.13 (0.44-2.91) 0.800
Recessive model
A/A-A/G 59 (98.3) 214 (99.5) Reference
G/G 1 (1.7) 1 (0.5) 0.28 (0.02-4.47) 0.380
rs2306862
Dominant model
C/C 39 (68.4) 154 (75.5) Reference
C/T-T/T 18 (31.6) 50 (24.5) 0.70 (0.37-1.34) 0.290
Recessive model
C/C-C/T 56 (98.2) 202 (99.0) Reference
T/T 1 (1.8) 2 (1.0) 0.55 (0.05-6.23) 0.650
Note: rs3736228 was not analyzed due to none of its homozygous variant - TT genotype was detected
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Table 4 Association between LRP5 genotypes and parameters of studied population
Characteristic rs3736228 p-value rs41494349 p-value rs2306862 p-value
CC CT AA AG+GG CC CT+TT
Age (years) 58 (45–73) 55 (45–75) 0.002 58 (45–75) 57 (45–72) 0.989 58 (45–73) 56 (45–75) 0.224
N 210 67 245 30 193 68
BMI (kg/m2) 22.77 (15.46–39.54) 22.88 (18.75–33.91) 0.804 22.77 (15.46–39.54) 23.14 (19.34–30.47) 0.878 22.55 (15.46–39.54) 23.06 (18.44–33.91) 0.350
N 210 67 245 30 193 68
Lumbar spine BMD (g/cm2) 1.018 (0.700–1.564) 0.983 (0.778–1.555) 0.584 1.013 (0.700–1.564) 1.003 (0.778–1.353) 0.388 1.013 (0.700–1.564) 0.993 (0.778–1.555) 0.787
N 160 45 183 22 147 46
Femoral neck BMD (g/cm2) 0.787 (0.434–1.204) 0.789 (0.612–1.224) 0.728 0.785 (0.434–1.204) 0.831 (0.562–1.224) 0.154 0.785 (0.434–1.141) 0.788 (0.548–1.224) 0.905
N 178 55 210 23 165 56
Total radial BMD (g/cm2) 0.469 (0.265–0.961) 0.500 (0.262–0.623) 0.011 0.475 (0.262–0.961) 0.475 (0.353–0.584) 0.702 0.471 (0.265–0.961) 0.485 (0.262–0.623) 0.191
N 210 67 245 30 193 68
Radial 33 BMD (g/cm2) 0.614 (0.315–0.785) 0.657 (0.350–0.818) 0.001 0.623 (0.315–0.818) 0.634 (0.447–0.722) 0.769 0.613 (0.315–0.785) 0.649 (0.350–0.818) 0.015
N 210 67 245 30 193 68
Total hip BMD (g/cm2) 0.870 (0.229–1.281) 0.875 (0.636–1.322) 0.565 0.870 (0.229–1.322) 0.909 (0.600–1.252) 0.625 0.869 (0.229–1.281) 0.876 (0.636–1.322) 0.636
N 178 55 210 23 165 56
















LRP5, a co-receptor for the Wnt signaling pathway, is
an important regulator for bone homeostasis [28].
Polymorphisms of LRP5 have been demonstrated to
have an influence on BMD and to be associated with
an increased risk of osteoporosis. We investigated the
effect of genetic variation of LRP5 on BMD in Thai
menopausal women.
Departure from HWE was detected in the rs3736228
genotype distribution. The most common cause of devi-
ation from HWE is genotyping error [29]. However,
for SNP it tends to be due to a deficit of heterozy-
gotes, making allele dropout the most frequent cause
of genotyping error [30]. On the contrary, with re-
spect to our results however, it was likely due to a
lack of homozygotes and the number of heterozygotes
being higher than expected. This is in agreement with
the Lewis phenotyping study showing that the cause
of departure from HWE was a deficit of homozygotes
[31].
In this study, we found that heterozygous risk allele
carriers, the T-allele of rs3736228 (CT), had a signifi-
cantly higher total radial BMD than those carrying
homozygous C-allele carriers (CC), p = 0.011 (N =
210 vs 67, respectively). In addition, the risk allele
carriers of rs3736228 and rs2306862 had a signifi-
cantly higher radial 33 BMD than those with the
wild-type allele (p = 0.001 (N = 210 vs 67) and p =
0.015 (N = 193 vs 68), respectively). However, the
wild-type allele carrier group of rs3736228 was older
than the risk allele group. Aging is an important
confounding factor in osteoporosis, and an increase
of age makes people more prone to developing
osteoporosis, coinciding with a lower BMD. There-
fore, it is likely that aging contributes to the lower
radial BMD found in the wild-type group of
rs3736228, as observed from logistic regression ana-
lysis. In postmenopausal women, age is reported to
be the second most important predictor of BMD vari-
ation [32].
These findings are contradictory to previous studies in
LRP5 SNPs, whereby subjects with a risk allele have a
lower BMD. The rs3736228 is associated with low BMD
in various ethnic groups [18–21]. Furthermore, the
association of rs2306862 and rs41494349 with BMD has
been reported predominantly within the Asian popula-
tion [23–25]. However, we failed to demonstrate the
association of rs41494349 with BMD in our study.
The strong LD found between rs3736228 and rs2306862
is in agreement with a study by Mizuguchi et al [23]. In
this study, the researchers identified an LD block between
intron 7 and exon 18 of the LRP5 gene in the Japanese
women. This included rs2306862 on exon 10 and
rs3736228 on exon 18. Haplotype blocks distribution
generated by Haploview gave similar LD patterns between
these two SNPs in CHB and JPT populations of HapMap.
Although the TT haplotype showed a protective effect
against osteopenia/osteoporosis, it disappeared after
adjusting for age. This is likely because in the rs3736228
SNP, the wild-type allele carrier group was older than the
risk allele group.
Our rs3736228 heterozygous risk allele carriers had a
higher total radial BMD compared with the wild-type,
which is in contrast to the majority of previous studies of
LRP5 polymorphisms, in which the rs3736228 risk allele
carrier is associated with a reduced BMD [18–21].
However, our finding is consistent with two previous stud-
ies of rs3736228 in men. Kiel et al. showed that men with
a reduced physical activity level carrying the risk allele of
rs3736228 have a higher spine BMD, whereas Kruk et al
found that men with no reported physical activity level
have a high BMD at all hip sites [33, 34].
Both the Kiel and Kruk research groups suggest involve-
ment of physical activity and mechanical loading in modulat-
ing the effect of LRP5 on bone remodeling balance in
response to physical exercise or on BMD determination.
The mechanism by which the different alleles of rs3736228
polymorphism interact through physical activity to modify
bone or BMD is unknown. However, LRP5 and Wnt/beta-
catenin signaling have been identified as essential compo-
nents of mechanically induced signal transduction [35, 36].
Loading increases Wnt signaling pathway expression and
Wnt/beta-catenin target genes; however, there is no response
to mechanical loading in mice with deletion of Lrp5 [37, 38].
Estrogen receptor alpha (ER-alpha) is involved in the bone
adaptation process to mechanical loading [39]. Moreover,
the LRP5 and ER-alpha pathway are reported to interact
during mechanical loading [40]. One study investigating
Table 5 Haplotype analysis: rs3736228 (C/T) and rs2306862 (C/T) SNP association using radial 33 BMD T-score cut-off
Haplotypea Normal (Frequency) Osteopenia/osteoporosis (Frequency) OR 95% CI p-value
CC 0.8331 0.8849 Reference haplotype
TT 0.1418 0.0810 0.48 (0.26–0.88) 0.018
CT 0.0146 0.0298 1.85 (0.56–6.08) 0.310
p<0.05 was considered statistically significant
OR odds ratio, 95% CI 95% confidence interval
a Haplotype analysis was performed by SNPStat program [27]
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Fig. 1 (See legend on next page.)
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gene-exercise interactions on BMD, showed an association
between physical activity and ER-alpha polymorphism on
BMD modulation at the loaded bone sites [41]. Furthermore,
an interleukin-6-association study showed that its genetic
variant influences cortical bone resorption during exercise
[42]. Accordingly, it is possible that LRP5 could have an
effect on BMD in response to physical activity. Although no
study has directly assessed the role of LRP5 polymorphism,
it remains to be determined if this polymorphism has an
interaction with mechanical loading via physical activity or
exercise, finally resulting in BMD change.
Our study has several limitations. First, because the
DNA used for genotyping was derived from stored spec-
imens, the sample size was fixed. Second, the available
BMD data was much smaller in comparison with the
genotyping data. Third, age is an important confounding
factor for osteoporosis, which significantly different
between the wild-type and risk allele carrier groups of
rs3736228. Therefore, we cannot avoid or exclude the
confounding factor effect of age. Fourth, our data
deviated from HWE because of the higher incidence of
heterozygotes found than expected. Taken together, this
leads to difficulties in statistical analysis; giving rise to
false positives or negatives and even non-significant re-
sults. Lastly, other potential confounders, such as years
since menopause, physical activity, smoking, alcohol
consumption and others, were not assessed.
Conclusions
From our findings and limitations, it seems that LRP5 poly-
morphisms are not a risk factor for osteoporosis in Thai
menopausal women. However, this research is not conclu-
sive and further studies with a larger sample size, and that
address all the aforementioned limitations, will help clarify
the role of LRP5 as a genetic determinant of osteoporosis.
Methods
Study population
The original research project was the collaboration
between the Department of Obstetrics and Gynecology,
Faculty of Medicine, Ramathibodi hospital and the
Department of Tropical Nutrition and Food Science,
Faculty of Tropical Medicine with EC approval from
Ramathibodi hospital since 2009. Data and blood collection
was performed at the Ramathibodi hospital and the experi-
ments were performed at the Faculty of Tropical Medicine.
In the present study, we used stored specimen left from
that original project with permission and EC approval.
In this study, subjects included 277 menopausal Thai
women who attended the menopause post-operation
follow-up clinic at the Department of Obstetrics and
Gynecology, Ramathibodi Hospital, Bangkok, Thailand. In-
clusion criteria used were: (1) women with 45 years of age
or older; (2) not having serious disease history; (3) not re-
ceiving vitamin/mineral for bone supplement; and (4) willing
to participate in the study. All subjects were in good health
and gave informed consent to participate in the study. Ex-
clusion criteria included any known diseases that could
affect bone metabolism such as hyperthyroidism, hyperpara-
thyroidism, rheumatoid arthritis, rickets and osteomalacia,
hypogonadism, type I diabetes mellitus, and Cushing’s syn-
drome. Physical examinations were conducted by the same
physician. The study protocol was approved by the Ethics
committees of the Faculty of Tropical Medicine and Faculty
of Medicine (Ramathibodi Hospital), Mahidol University,
Bangkok, Thailand.
BMD measurement
Bone mineral density (BMD, g/cm2) was assessed at the
lumbar spine (L2–L4), femoral neck, total radius, radial 33,
and total hip using dual-energy X-ray absorptiometry
(DEXA) (Lumar Prodigy, Lunar, USA) by a single, experi-
enced technician.
DNA extraction and genotyping
Genomic DNA was extracted from EDTA-treated periph-
eral blood samples using the Flexi Gene DNA kit (Qiagen,
Hilden, Germany). Genomic DNA was stored at −70 °C for
further analysis. Genotyping of LRP5 SNP variation was
(See figure on previous page.)
Fig. 1 Linkage disequilibrium plot between LRP5 SNPs showing region the rs3736228 and rs2306862 located using HapMap populations determined
by Haploview 4.2 program. Each black triangle depicts haplotype blocks. LD is reported as D’. Bright red represents D’ = 1 and LOD ≥ 2, blue
represents D’ = 1 and LOD < 2, pink represents D’ < 1, and LOD ≥ 2, and white represents D’ < 1 and LOD < 2. The r2 values are shown in blocks.
The rs3736228 and rs2306862 are indicated by boxes. CHB, Han Chinese in Beijing, China; JPT, Japanese in Tokyo, Japan
Table 6 Logistic regression analysis of osteopenia/osteoporosis risk factors using total radial BMD T-score cut-off for osteoporosis
Factors Crude OR 95% CI p-value Adjusted OR* 95% CI p-value
rs3736228 2.67 0.91-7.88 0.075 2.43 0.74-7.99 0.144
BMI (≤25 kg/m2) 6.80 1.59-29.15 0.010 10.70 2.28-50.24 0.003
Age (increases every 10 years) 5.00 2.62-9.54 <0.001 6.32 3.05-13.07 <0.001
BMD bone mineral density, OR odds ratio, 95% CI 95% confidence interval
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conducted using the polymerase chain reaction-restriction
fragment length polymorphism (PCR-RFLP) method.
The forward and reverse primers for A1330V
(rs3736228) SNP were designed as 5′-GACTGTCAGGA
CCGCTCACACG-3′ and 5′-AAGGTTTTCAGAGCCCC
TAC-3′, respectively. The PCR product was cut by DraIII
(New England Biolabs, Beverly, CA) and separated by 6 %
polyacrylamide gel electrophoresis. DNA from a subject
homozygous for the C allele appeared as a band of 143 bp
in length relative to the 100 bp size marker. The T allele
constructs cut site for DraIII, and DNA from a subject
homozygous for the T allele, appeared as bands of 119 and
24 bp, respectively [25].
The forward and reverse primers for Q89R (rs41494349)
SNP were designed as 5′-CTCTGGGCATAGTGCTCCA
TC-3′ and 5′-CCGGAGATGACCACGTTCTG-3′, re-
spectively. The PCR product was cut by AvaI (New
England Biolabs, Beverly, CA) and separated by 6 %
polyacrylamide gel electrophoresis. DNA from a subject
homozygous for the A allele appeared as a band of 308 bp
in length relative to the 100 bp size marker. The G allele
constructs cut site for AvaI, and DNA from a subject
homozygous for the G allele, appeared as bands of 257
and 51 bp, respectively.
The forward and reverse primers for N740N (rs2306862)
SNP were designed as 5′-CTACTGGGCCGACACTGG
GATTAA-3′ and 5′-ACAGCTCTAATCACCGAGGG-3′,
respectively. The PCR product was cut by AseI (New
England Biolabs, Beverly, CA) and separated by 6 %
polyacrylamide gel electrophoresis. DNA from a sub-
ject homozygous for the C allele appeared as a band
of 237 bp in length relative to the 100 bp size
marker. The T allele constructs cut site for AseI, and
DNA from a subject homozygous for the T allele ap-
peared as bands of 216 and 21 bp, respectively [25].
Results have been either randomly duplicated checked
and performed direct sequencing. Resolution of 24 bp
(A1330V), 51 bp (Q89R) and 21 bp (N740N) cleaved
products cannot be resolved in 6 % PAGE and are invis-
ible on the gel. Therefore, only DNA bands with larger
size for each SNP can be seen. Gel depicted 3 SNPs
genotyping is shown below in Fig. 2.
Statistical analysis
The SPSS v.15.0 program for Windows (SPSS, Chicago, IL)
was used to analyze the median, range and p value
(Mann–Whitney U test) between groups. Departure from
Hardy–Weinberg Equilibrium (HWE) of allele frequency
for each SNP was tested by the Chi-square test. Linkage
disequilibrium (LD) and haplotype analysis were performed
using the SNPStat web tool program [43]. LD plot of
CHB and JPT populations genotype data from Hap-
Map phase 3 (June 15, 2016) was generated using
Haploview 4.2 program [44].
Univariate analysis was performed to determine any
factor that had an effect on osteoporosis, represented by
total radial BMD T-score cut-off for osteoporosis. Any
variable with p ≤ 0.1 in univariate analysis was further
analyzed in stepwise multivariate logistic regression
analysis using a backward Wald method for determining
independent associated factors for osteoporosis. Back-
ward Wald method is a stepwise entry method used to
construct the logistic regression model by removing
explanatory variables from the full model that including
all the specified explanatory variables. All tests of signifi-
cance were 2-sided, and a p-value <0.05 was considered
statistically significant.
Additional file
Additional file 1: Haplotype blocks distribution in the LRP5 gene of CHB
and JPT populations of HapMap generated by Haploview 4.2 program.
Each black triangle depicts haplotype blocks. LD is reported as D′. Bright red
represents D' = 1 and LOD≥ 2, blue represents D' = 1 and LOD < 2, pink
represents D' < 1, and LOD≥ 2, and white represents D' < 1 and LOD < 2.
The r2 values are shown in blocks. CHB, Han Chinese in Beijing, China; JPT,
Japanese in Tokyo, Japan.
308 bp
257 bp 237 bp
216 bp
M A1330V
CC   CT
143 bp
119 bp
Fig. 2 Fragment patterns of LRP5 SNPs with a 100 bp marker. M, Marker
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